Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Durvalumab + Tremelimumab for Liver Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial is testing the side effects of two cancer-fighting antibodies and their effectiveness in treating patients with liver cancer that has spread too far to be removed by surgery.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service